Effects of oral paricalcitol on secondary hyperparathyroidism and proteinuria of kidney transplant patients.

Gonzalez, Esther; Rojas-Rivera, Jorge; Polanco, Natalia; Morales, Enrique; Morales, José María; Egido, Jesus; Amado, Andres; Praga, Manuel

Gonzalez, Esther; Rojas-Rivera, Jorge; Polanco, Natalia; Morales, Enrique; Morales, José María; Egido, Jesus; Amado, Andres; Praga, Manuel.

Transplantation ; 95(7): e49-52, 2013 Apr 15.

Article in En | MEDLINE | ID: mdl-23545517

Subject(s)

Ergocalciferols/administration & dosage; Hyperparathyroidism, Secondary/drug therapy; Kidney Transplantation/adverse effects; Proteinuria/drug therapy; Administration, Oral; Adult; Aged; Biomarkers/blood; Glomerular Filtration Rate/drug effects; Humans; Hyperparathyroidism, Secondary/blood; Hyperparathyroidism, Secondary/etiology; Hyperparathyroidism, Secondary/physiopathology; Kidney/drug effects; Kidney/physiopathology; Logistic Models; Middle Aged; Multivariate Analysis; Odds Ratio; Parathyroid Hormone/blood; Proteinuria/etiology; Proteinuria/physiopathology; Risk Factors; Time Factors; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proteinuria / Ergocalciferols / Kidney Transplantation / Hyperparathyroidism, Secondary Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Transplantation Year: 2013 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google